WHO okays arthritis drug for severe COVID-19 cases
The World Health Organization -WHO, has prequalified the rheumatoid arthritis drug Tocilizumab for the treatment of severe Covid-19 patients.
The monoclonal antibody, used in anti-inflammatory drugs made by Swiss pharma giant Roche, has…